PALO ALTO, Calif., Feb. 8, 2011 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin McGlynn will present an update on the Company's programs and operations at the 13th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference to be held February 14-15 in New York City. Mr. McGlynn is scheduled to speak at 1:00 p.m. Eastern Time on Tuesday, February 15.
